The MATE study : a 24 month, multicentre, pilot, randomised controlled trial comparing standard care with individualised treat and extend regimen for treatment of neovascular age-related macular degeneration with aflibercept
(2019)
Thesis
Airody, A. (2019). The MATE study : a 24 month, multicentre, pilot, randomised controlled trial comparing standard care with individualised treat and extend regimen for treatment of neovascular age-related macular degeneration with aflibercept. (Thesis). Hull York Medical School, the University of Hull and the University of York. Retrieved from https://hull-repository.worktribe.com/output/4222537
Purpose: Various treatment regimens have been described for anti-vascular endothelial growth factors (VEGF) in neovascular age-related macular degeneration (nvAMD). Recently, these include treating nvAMD with aflibercept using a ‘Treat & Extend’ (T&E... Read More about The MATE study : a 24 month, multicentre, pilot, randomised controlled trial comparing standard care with individualised treat and extend regimen for treatment of neovascular age-related macular degeneration with aflibercept.